Zinzino Reports 17 Percent Revenue Growth in Second Quarter

The company’s primary sales markets drove the quarterly performance, contributing SEK 914.9 million to the total. While regional results varied, North America emerged as a significant growth engine, recording a 51 percent surge in quarterly revenue to SEK 207.8 million. South American operations also saw triple-digit expansion, albeit from a smaller base, jumping 326 percent to SEK 10.2 million.

Performance across other territories proved mixed. Central Europe maintained steady momentum with a 28 percent increase, totaling SEK 280.7 million. Conversely, markets in Eastern Europe and the Asia-Pacific region faced headwinds, with revenues contracting by 9 percent each during the same period. Faun Pharma, the group’s manufacturing subsidiary, added SEK 15.3 million to the total quarterly revenue, reflecting a modest 2 percent year-over-year improvement.